0 of 14 questions completed
You have already completed the assessment before. Hence you can not start it again.
Assessment is loading…
You must sign in or sign up to start the assessment.
You must first complete the following:
0 of 14 questions answered correctly
Time has elapsed
You have reached 0 of 0 point(s), (0)
Earned Point(s): 0 of 0, (0)
0 Essay(s) Pending (Possible Point(s): 0)
Which of the following is a type of myelodysplastic syndrome (MDS):
The most common side effects of lenalidomide are neutropenia and thrombocytopenia. Which of the following tests should be done regularly to monitor cytopenias when a patient is taking lenalidomide:
Improvement in overall survival and prevention of progression to AML are general treatment goals in which type of MDS:
Erythropoiesis stimulating agents utilized in MDS:
Which agent prolongs overall survival in higher risk MDS patients?
Treatment options for MDS patients include all but:
Deferoxamine is administered:
When using erythropoiesis-stimulating agents:
Lenalidomide is an agent that:
Which is not true when administering antithymocyte globulin, specifically equine ATG:
Myelodysplastic syndromes result from abnormal development of the myeloid cells in the bone marrow:
Treatment for poor appetite may include all of the following except:
The biopsychosocial approach to care of MDS patients includes considerations such as:
The role of the social worker may include assisting the patient with: